Meningococcal polysaccharide vaccination of military recruits in Israel: Preliminary assessment of vaccine effect

Daniel Mimouni; Michael Gdalevich; Yosef Mandel; Moti Haim; Isaac Ashkenazi; Joshua Shemer; Colin Block

doi:10.1080/00365549850160909

Meningococcal polysaccharide vaccination of military recruits in Israel: Preliminary assessment of vaccine effect

Daniel Mimouni
, Michael Gdalevich
, Yosef Mandel
, Moti Haim
, Isaac Ashkenazi
, Joshua Shemer
, Colin Block

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Meningococcal disease in the Israel Defense Force is caused mainly by serogroups C and Y. Immunization of recruits with quadrivalent polysaccharide vaccine was introduced in November 1994. The person-time incidence rate dropped from 1.33 cases per 100,000 person-years for the preceding decade to 0 for the 32 months following immunization (p = 0.025).

Original language	English
Pages (from-to)	263-264
Number of pages	2
Journal	Scandinavian Journal of Infectious Diseases
Volume	30
Issue number	3
DOIs	https://doi.org/10.1080/00365549850160909
State	Published - 1998
Externally published	Yes

Bibliographical note

Medical Corps, Israel Defense Force

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1080/00365549850160909

Cite this

@article{e0d3e615cf1f446386b02920ae487339,

title = "Meningococcal polysaccharide vaccination of military recruits in Israel: Preliminary assessment of vaccine effect",

abstract = "Meningococcal disease in the Israel Defense Force is caused mainly by serogroups C and Y. Immunization of recruits with quadrivalent polysaccharide vaccine was introduced in November 1994. The person-time incidence rate dropped from 1.33 cases per 100,000 person-years for the preceding decade to 0 for the 32 months following immunization (p = 0.025).",

author = "Daniel Mimouni and Michael Gdalevich and Yosef Mandel and Moti Haim and Isaac Ashkenazi and Joshua Shemer and Colin Block",

note = "Medical Corps, Israel Defense Force",

year = "1998",

doi = "10.1080/00365549850160909",

language = "אנגלית",

volume = "30",

pages = "263--264",

journal = "Scandinavian Journal of Infectious Diseases",

issn = "0036-5548",

publisher = "Taylor and Francis Ltd.",

number = "3",

}

TY - JOUR

T1 - Meningococcal polysaccharide vaccination of military recruits in Israel

T2 - Preliminary assessment of vaccine effect

AU - Mimouni, Daniel

AU - Gdalevich, Michael

AU - Mandel, Yosef

AU - Haim, Moti

AU - Ashkenazi, Isaac

AU - Shemer, Joshua

AU - Block, Colin

N1 - Medical Corps, Israel Defense Force

PY - 1998

Y1 - 1998

N2 - Meningococcal disease in the Israel Defense Force is caused mainly by serogroups C and Y. Immunization of recruits with quadrivalent polysaccharide vaccine was introduced in November 1994. The person-time incidence rate dropped from 1.33 cases per 100,000 person-years for the preceding decade to 0 for the 32 months following immunization (p = 0.025).

AB - Meningococcal disease in the Israel Defense Force is caused mainly by serogroups C and Y. Immunization of recruits with quadrivalent polysaccharide vaccine was introduced in November 1994. The person-time incidence rate dropped from 1.33 cases per 100,000 person-years for the preceding decade to 0 for the 32 months following immunization (p = 0.025).

UR - https://www.scopus.com/pages/publications/0031709846

U2 - 10.1080/00365549850160909

DO - 10.1080/00365549850160909

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

SN - 0036-5548

VL - 30

SP - 263

EP - 264

JO - Scandinavian Journal of Infectious Diseases

JF - Scandinavian Journal of Infectious Diseases

IS - 3

ER -

Meningococcal polysaccharide vaccination of military recruits in Israel: Preliminary assessment of vaccine effect

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this